Focus Partners Wealth Invests $243,000 in VanEck Pharmaceutical ETF (NASDAQ:PPH)
Focus Partners Wealth bought a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor bought 2,815 shares of the company’s stock, valued at approximately $243,000. Other institutional investors and hedge funds have also made changes to their positions in the company. SBI Securities Co. […]
Focus Partners Wealth bought a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor bought 2,815 shares of the company’s stock, valued at approximately $243,000. Other institutional investors and hedge funds have also made changes to their positions in the company. SBI Securities Co. […]
